Spectranetics Google Finance

Spectranetics was a medical device company specializing in products used in minimally invasive procedures to remove unwanted tissue, known as excimer laser atherectomy. While Spectranetics is no longer a publicly traded company listed under that name, its history and its representation on platforms like Google Finance offer valuable insights into the dynamics of the medical technology market.

Historically, Spectranetics' Google Finance page provided investors with real-time stock quotes (before its acquisition), historical price data, company news, financial statements, and key ratios. This allowed potential investors to assess the company's financial health, growth potential, and overall performance. The data typically included information like:

• Stock Price Performance: Tracking the daily, weekly, monthly, and yearly price movements of the stock, providing a visual representation of investor sentiment.
• Financial Statements: Access to balance sheets, income statements, and cash flow statements, enabling investors to analyze revenue trends, profitability, and debt levels.
• Key Ratios: Metrics like price-to-earnings ratio (P/E), earnings per share (EPS), and debt-to-equity ratio, offering insights into valuation and financial risk.
• News and SEC Filings: Providing timely updates on company announcements, regulatory filings, and significant events that could impact the stock price.

The information accessible via Google Finance and other financial platforms helped investors understand Spectranetics' business model, which revolved around designing, manufacturing, and marketing laser-based systems and related disposable catheters for the treatment of cardiovascular and peripheral vascular diseases. These systems allowed physicians to remove blockages in arteries, improving blood flow and addressing conditions like peripheral artery disease (PAD) and coronary artery disease (CAD).

However, the stock is no longer listed under that name since Spectranetics was acquired by Philips in 2017. Philips acquired Spectranetics to expand its portfolio of image-guided therapy devices. Philips believed that Spectranetics' atherectomy devices would complement its existing interventional cardiology and peripheral vascular offerings, creating a broader and more comprehensive solution for treating cardiovascular disease.

Following the acquisition, Spectranetics' operations were integrated into Philips' Image Guided Therapy business group. This meant that Spectranetics' products and technologies were now marketed and sold under the Philips brand.

Although the historical data remains accessible on platforms like Google Finance, the ticker symbol is no longer active. Investors now need to look to Philips (PHG) to understand the ongoing performance of the Spectranetics' acquired technology. Analysis of Philips' financial reports and investor presentations can provide insights into how the acquired Spectranetics assets are contributing to Philips' overall growth and profitability in the medical device sector. The story of Spectranetics, as documented on Google Finance and other financial data sources, serves as a case study in the medical device industry, illustrating the potential for innovation, growth, and ultimately, acquisition by larger players seeking to expand their market share and technological capabilities.